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THE PERCUTANEOUS ABSORPTION OF ESTRADIOL-178 AND
PROGESTERONE*
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The percutaneous absorption (1—3) and local
action (4, 5) of steroid hormones have been
known for many years. Studies of the extent of
such absorption have been hampered by the lack
of reliable and sensitive methods. Changes in the
vaginal cytology consequent to estrogen adminis-
tration have provided a rough measure of
systemic effects. However this index, being in
essence a form of bioassay, cannot be considered
to yield quantitative information. With testos-
terone or progesterone, the methods for de-
tecting percutaneous absorption are even less
satisfactory. Radioactive steroids of high specific
activity provide an ideal instrument for investi-
gations of this kind (13—15), and with the
availability of compounds labelled with different
isotopes the behavior and interaction of several
steroids can be observed simultaneously.
MATERIALS AND METHODS
Adult male guinea-pigs were used in the animal
studies. The backs were completely shaved from
the midcervical area to the level of the iliac crest
and the radioactive steroid-containing ointment
applied over a 2 x 2 inch (25 cm2) interscapular
area 2—5 days after shaving. The region was
covred with heavy aluminum foil, completely
enclosed with adhesive tape and kept in this
condition for the duration of each experiment.
In the studies with three adult women between
35 and 50 years of age, a 12 x 12 inch (625 cm2)
lumbodorsal area was used; application was
carried out in the same manner and maintained
for 24 hours. At the completion of each experiment
the adhesive and aluminum foil were removed and
the integument wiped softly but very thoroughly
with cotton dampened with 95 per cent ethanol.
The adhesive tape, foil, rubber gloves and cotton
used in cleansing were combined, extracted, and
the radioactivity of the extract determined. The
same procedure was applied to materials used in
the application of the radioactive ointment, and
in this manner the net number of counts applied
was determined. All calculations are based on this
net count.
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In the animal studies (3 animals per experiment)
the steroid application consisted of 0.5 gm. oint-
ment basef into which was incorporated 2.6 pg.
6,7-H'-estradiol-lTh with an activity of 2.0 X
10 dpm and 41.3 pg progesterone-4-C'4 with an
activity of 2.0 X 106 dpm. In some experiments
16.6 pg nonradioactive estrone was added as well.
In the human experiments 2.0 gm. ointment was
used, and it contained 0.52 pg. 6,7-H3-estradiol-
17fl with an activity of 2.0 X 10 dpm, 346 pg.
progesterone-4-C14 with an activity of 5 X 10
dpm and 66 pg. estrone.
Urine was collected over the entire period of
the application in the animal studies; in the human
subjects 24-hour urines were obtained during the
period of application and for 2 days thereafter.
Guinea-pig urine showed sufficiently high activity
so that very small aliquots could be assayed with-
out chemical concentration of the steroid metabo-
lites. With human urines, 50—100 ml. aliquots were
incubated with 35,000 to 75,000 units of 3-glucuron-
idase (Ketodase) at pH 4.6 for 72 hours at 37° C.
and extracted with ethyl acetate. The residual
urine was acidified to 2N with sulfuric acid and
extracted with ethyl acetate, which was incubated
for 72 hours at 37° C. (6). Finally, the residual
urine was refluxed with 15 vol. percent concen-
trated HCl for 2 hours and extracted with ethyl
acetate. The extracts were evaporated to dryness
and examined separately.
At the termination of each experiment, the
guinea pigs were sacrificed, and weighed aliquots
of representative tissues homogenized and the
lipids extracted with methanol-methylal (7).
The tissue residue was hydrolyzed completely
in 2.5 N NaOH, neutralized, and extracted with
ether. Small aliquots of the lipid extracts were
counted and the ether extracts were also studied to
determine any residual tissue radioactivity. Ex-
traction was quantitative throughout. Radio-
activity was measured in duplicate samples by
liquid scintillation in toluene with POP and
POPOP as phosphors (8) using a Packard Tn-
Carbs pectrometer modified according to Blau
(9). This permitted simultaneous counting of
tnitium and C14. All samples were examined for
quenching using an internal standard of C14
benzoic acid; in case of significant quenching
further dilution or purification was used. Each
f Ointment base No. 6043, supplied by H. R.
Laboratories, Inc., Greenvale, L. I.
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sample was counted 10 times to a suitable re-
producibility and to a statistical counting ac-
curacy of better than 5 percent.
RESULTS AND DISCUSSION
In the first extracts of human urine an
average of 88 per cent of the radioactive estradiol
metabolites and 92 per cent of the radioactive
progesterone metabolites were recovered, inch-
eating that they were either free or present as
glucuronides. The remainder of the radioactivity
was present as sulfates which were released by
the second (solvolysis) extraction. There was no
radioactivity in the mineral acid hydrolysis ex-
tract except for 2 instances where 0.6 and 2.5 per
cent of the C14 activity was recovered. No attempt
was made to identify the various radioactive
metabolites of estradiol and progesterone, since
we were interested in the excretion of the total
metabolic products. The individual metabolites
of estrogens and progesterone administered by
other routes have been investigated and identified
by numerous workers, and there is no evidence to
suggest that a change in the route of administra-
tion would cause qualitative alterations of the
known metabolic pathways.
The urinary excretion of radioactive metabo-
lites in the human subjects is shown in Table 1.
As might be expected, there is complete inde-
pendence of the excretion patterns of estradiol
and progesterone metabolites. The maximum
excretion of estradiol metabolites occurred on
day 2 in all instances, whereas the maximum
excretion of progesterone metabolites occurred on
TABLE 1
Per cent of radioactive steroid metaboliles appearing
in urine of women. Day 1 represents period during
which ointment was in contact with the skin
Human Subject
Per Cent Excretion
Day 1 Day 2 Day 3 Total
A. Estradiol-17$ metabolites
A (age 36)
B (age 50)
C (age 39)
3.9
7.1
7.9
19.0
11.4
25.1
2.4
3.5
11.1
25.3
22.0
44.1
B. Progesterone metabolites
A
B
C
1.0
2.2
2.0
4.4
3.1
2.9
14.7
11.2
38.0
20.1
16.5
42.9
TABLE 2
Per cent of radioactive metabolites appearing in
urine of guinea-pigs during various periods
of topical steroid application
Group Noials ApplicationTime,
Hours
Added
Estronc
Urinar' Excretion,
Per Cent
Mean (range)
A. 6,7 H3-estradiol-173 metabolites
1.
2.
3.
4.
3
3
3
3
14
108
108
120
+
—
+
+
0.21
1.69
2.49
3.58
(0.08—0.44)
(1.40—2.02)
(1.97—3.23)
(2.21—4.60)
B. 4C14 Progesterone metabolites
1.
2.
3.
4.
3
3
3
3
14
108
108
120
+
—
+
+
0.07
1.12
4.25
9.07
(0.02—0.09)
(0.99—1.68)
(3.07—5.83)
(6.32—12.4)
day 3. This is consistent with the relatively slow
excretion of progesterone administered intra-
muscularly or intravenously (10) as compared to
other steroids, and is attributed to greater
storage of progesterone in the body fat (11). It
is also noteworthy that one subject excreted (and
must have absorbed) twice as much of both
steroids as the others.
In the studies on guinea pigs, (Table 2) urine
collected during the entire period of the ointment
application was pooled and consequently the lag
in progesterone metabolite excretion does not
appear clearly. After 4 hours of application, only
0.21 per cent of the tritium (i.e. estradiol metabo-
lites) and 0.07 per cent of the C' (i.e. proges-
terone) metabolites appear in the urine. This ratio
is similar to that observed in humans after 24
hours of application, but the numbers are sta-
tistically not conclusive. There is an interesting
difference between the 2 groups of animals
treated for 108 hours: the animals given an
ointment also containing estrone excrete a larger
proportion of the topically administered radio-
activity, and this is particularly evident for the
metabolites of progesterone. This observation
requires further study with larger numbers of
animals. By 120 hours, the urinary progesterone
metabolites are twice as high as the estradiol
metabolites, suggesting that the percutaneous
absorption of progesterone is more rapid than
that of estradiol. The fact that a larger fraction
of progesterone metabolites are known to be lost
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TABLE 3
Per cent of radioactivity in various organs after topical application of radioactive steroids. "Hide" includes
area of topical application plus wide margin of surrounding skin. Total weight of excised hide ranged
from 19.1 to 36.5 gm
Group N(,O mroup
Application
Tune,
Hours
Estrone
Per cent of Administered Dose in Entire Organ
Hide Liver Kidneys
mean (range) mean (range) mean (range)
A. H' (estrogen radioactivity)
1.
2.
3.
4.
3
3
2
2
14
108
108
120
+
—
+
+
55.0 (37.9—77.3)
26.8 (16.0—43.4)
28.0 (16.5—39.5)
26.7 (43—49.1)
3.40 (2.64—4.28)
1.64 (0.40—2.92)
0.41 (0.24—0.58)
0.72 (0.03—1.40)
0.09 (0.06—0.17)
1.77 (1.33—2.62)
0.70 (0.09—1.31)
0.32 (0.13—.051)
B. C14 (progestin radioactivity)
1.
2.
3.
4.
3
3
2
2
14
108
108
120
+
—
+
+
26.9 (19.5—36.8)
9.7 (5.9—15.3)
13.0 (4.7—21.2)
0.40 (0.30—0.50)
8.52 (1.93—18.6)
0.57 (0.1—0.96)
0.19 (0.13—0.25)
1.87 (0.04—3.69)
0.09 (0.01—0.25)
0.93 (0.44—1.33)
1.42 (1.33—1.50)
7.97 (0.28—15.7)
via the fecal pathway (12) adds support to this
belief.
The urinary excretion of steroids applied to
human skin for 24 hours totalled 16.5 to 44.1 per
cent in 72 hours; by contrast, the application of
radioactive steroids to shaved guinea-pig skin
for a period of 120 hours resulted in a urinary
excretion of only 2.2 to 12.4 per cent. These
very large differences call for great caution in
applying knowledge gained from one species to
questions involving another species.
Some question may be raised as to the effect of
the skin cleansing performed on the human
subjects at the end of the application. This
procedure was necessary in order to remove
residual steroids from the skin surface as com-
pletely as possible for precise calculation of
percentage recoveries. The abrasion involved was
certainly less than that sustained from the
ordinary wearing of clothes and it is not likely
that the barrier membrane was damaged or that
material was forced into the hair follicles. It is
conceivable that the alcohol with which the
cotton was dampened may have promoted
percutaneous absorption. However, inspection of
the data shows that at least 3.9 to 7.9 per cent of
the estradiol was absorbed and excreted prior to
the skin cleansing, and these values exceed the
total excretion over a period of 4 days in
guinea-pigs.
Table 3 summarizes the values for the total
tritium and C'4 radioactivity found in various
guinea-pig organs. In addition, testes, adrenals
and a sample of thigh muscle from each animal
were extracted and assayed; in all instances the
level of radioactivity in the tissue or whole organ
was less than 0.02 per cent of the administered
dose, and usually did not differ significantly
from the background count. The short term
experiment (group 1) adds further support to the
idea that the percutaneous absorption of proges-
terone is much more rapid than that of estradiol:
only 26.9 per cent of the C14 (progesterone)
radioactivity is associated with the hide com-
pared to 55.0 per cent of the tritium (estradiol)
activity. Moreover 8.5 per cent of the adminis-
tered C'4 is in the liver after 14 hours, as com-
pared to 3.4 per cent of tritium. It is also of
interest to note that about 25 per cent of the
administered estradiol radioactivity remains
associated with the integument after 120 hours,
whereas progesterone radioactivity passes
through rather readily, leaving only 0.40 per
cent. The presence or absence of carrier estrone
(groups 2 and 3) apparently does not affect the
amount of radioactivity remaining associated
with the integument. Differences between group
2 and 3, already noted in the total urinary
excretion of radioactivity, are also found in the
tissues. Less radioactivity—both tritium and
C'4—was observed in liver and kidneys when
carrier estrone was included in the ointment.
These differences, if substantiated by further
studies, suggest that increased concentrations of
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estrogen accelerate the percutaneous passage of
steroid hormones in guinea pigs.
SUMMARY
The topical application of radioactive estra-
diol-17f and progesterone in an ointment base
was studied in shaved guinea-pigs and in human
subjects. Upon application to human skin for 1
day, 16.5 to 44 per cent of the radioactivity
appeared in the urine within 72 hours and
approximately equal amounts of radioactivity
from each steroid were present. There was
significant individual variation. A lower rate of
urinary excretion was observed in guinea-pigs.
The percutaneous absorption of progesterone
seems to be more rapid than that of estradiol, and
there was some evidence suggesting that higher
concentrations of estrogen accelerate the percuta-
neous passage of these steroids.
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